Anderle, Karolina https://orcid.org/0000-0002-2572-9995
Sieghart, Daniela
Durechova, Martina
Bonnay, François
Kerschbaumer, Andreas
Chatzidionysiou, Katerina
Knevel, Rachel
Pitzalis, Costantino
Lillegraven, Siri
Haavardsholm, Espen A.
Kristianslund, Eirik Klami
Codreanu, Catalin
Popescu, Claudiu
Gremese, Elisa
de Geest, Sabina
Kocher, Agnes
Makri, Souzi
Aletaha, Daniel
Lechner-Radner, Helga https://orcid.org/0000-0002-5908-1525
,
Funding for this research was provided by:
HORIZON EUROPE Innovative Europe (101095052)
Article History
Received: 3 September 2025
Accepted: 29 January 2026
First Online: 23 March 2026
Declarations
:
: The study was approved by the European Medicines Agency (EMA) via CTIS and by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and local ethics committees. Details can be found in the Methods section.
: All authors gave their consent for publication of this manuscript.
: The authors declare that they have no competing interests.